166 related articles for article (PubMed ID: 38060044)
21. Use of physician assistants in Mohs micrographic surgery: a survey of fellowship-trained Mohs micrographic surgeons.
Hyde MA; Hadley ML; Roberson C; Jacobson A; Pappas L; Bowen GM
Dermatol Surg; 2010 Nov; 36(11):1700-3. PubMed ID: 20961351
[TBL] [Abstract][Full Text] [Related]
22. Characteristics and comorbidities of Medicare beneficiaries receiving care from Mohs micrographic surgeons based on fellowship training and practice setting.
Gronbeck C; Feng H
Dermatol Online J; 2021 Aug; 27(8):. PubMed ID: 34755958
[TBL] [Abstract][Full Text] [Related]
23. An ecological study of skin biopsies and skin cancer treatment procedures in the United States Medicare population, 2000 to 2015.
Wang DM; Morgan FC; Besaw RJ; Schmults CD
J Am Acad Dermatol; 2018 Jan; 78(1):47-53. PubMed ID: 28947293
[TBL] [Abstract][Full Text] [Related]
24. Association of Mohs Micrographic Surgery vs Wide Local Excision With Overall Survival Outcomes for Patients With Melanoma of the Trunk and Extremities.
Demer AM; Hanson JL; Maher IA; Liszewski W
JAMA Dermatol; 2021 Jan; 157(1):84-89. PubMed ID: 33084853
[TBL] [Abstract][Full Text] [Related]
25. Mohs Surgery for SEER Registry-Captured Melanoma In Situ and Rare Cutaneous Tumors: Comparing National Utilization Patterns Before and After Implementation of the Affordable Care Act (2010) and Appropriate Use Criteria (2012).
Garland K; Condon S; Xiong DD; Crowe D; Knackstedt TJ
Dermatol Surg; 2020 Aug; 46(8):1021-1029. PubMed ID: 31929340
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of wound complications following Mohs micrographic surgery (MMS): a cross-sectional study of 1000 patients undergoing MMS and wound repair in a UK teaching hospital.
Rutkowski D; Littlewood Z; Touyz SJJ; Collier NJ; Madan V; Ghura HS; Yiu ZZN; Telfer N
Clin Exp Dermatol; 2022 Aug; 47(8):1536-1542. PubMed ID: 35490302
[TBL] [Abstract][Full Text] [Related]
27. Cost effectiveness of Mohs micrographic surgery: review of the literature.
Tierney EP; Hanke CW
J Drugs Dermatol; 2009 Oct; 8(10):914-22. PubMed ID: 19852120
[TBL] [Abstract][Full Text] [Related]
28. Correlation of basal cell carcinoma subtype with histologically confirmed subclinical extension during Mohs micrographic surgery: A prospective multicenter study.
Lim GF; Perez OA; Zitelli JA; Brodland DG
J Am Acad Dermatol; 2022 Jun; 86(6):1309-1317. PubMed ID: 35231546
[TBL] [Abstract][Full Text] [Related]
29. Mohs micrographic surgery as treatment option for non-basal cell or squamous cell carcinomas in the United States.
Puyana C; Zimmerman L; Tsoukas MM
J Dermatolog Treat; 2020 Sep; 31(6):567-570. PubMed ID: 31474170
[No Abstract] [Full Text] [Related]
30. Demographics and outcomes of stage I and II Merkel cell carcinoma treated with Mohs micrographic surgery compared with wide local excision in the National Cancer Database.
Singh B; Qureshi MM; Truong MT; Sahni D
J Am Acad Dermatol; 2018 Jul; 79(1):126-134.e3. PubMed ID: 29408552
[TBL] [Abstract][Full Text] [Related]
31. Mohs micrographic surgery versus wide local excision for melanoma in situ: analysis of a nationwide database.
Phan K; Loya A
Int J Dermatol; 2019 Jun; 58(6):697-702. PubMed ID: 30604517
[TBL] [Abstract][Full Text] [Related]
32. Mohs micrographic surgery versus wide local excision for eyelid melanoma: An analysis of a national database.
Ramachandran V; Phan K
J Plast Reconstr Aesthet Surg; 2022 Dec; 75(12):4410-4415. PubMed ID: 36257889
[TBL] [Abstract][Full Text] [Related]
33. National utilization patterns of Mohs micrographic surgery for invasive melanoma and melanoma in situ.
Viola KV; Rezzadeh KS; Gonsalves L; Patel P; Gross CP; Yoo J; Stamell E; Turner RB
J Am Acad Dermatol; 2015 Jun; 72(6):1060-5. PubMed ID: 25824274
[TBL] [Abstract][Full Text] [Related]
34. Mohs surgeon workforce survey: a spectrum of clinical, academic, and leadership activities.
Scott JF; Lam C; Ahn JW; Yu SH
Arch Dermatol Res; 2023 Dec; 316(1):30. PubMed ID: 38060032
[TBL] [Abstract][Full Text] [Related]
35. The association between breast cancer capacity and resources with incidence and mortality in Arizona's low populous counties.
Lent AB; Mohan P; Derksen D; Cance WG; Barraza L; Jacobs ET; Calhoun EA
Rural Remote Health; 2021 Jul; 21(3):6357. PubMed ID: 34215158
[TBL] [Abstract][Full Text] [Related]
36. Unnecessary Cost of Post-Mohs Permanent Pathology.
MacArthur KM; Tang N; Hruza GJ; Wang TS; Egbers RG
Dermatol Surg; 2017 Oct; 43(10):1236-1239. PubMed ID: 28538028
[TBL] [Abstract][Full Text] [Related]
37. Consistency in Distribution of Facial Skin Cancers Treated With Mohs Micrographic Surgery.
Horeczko J; Hendi A
J Drugs Dermatol; 2022 May; 21(5):506-509. PubMed ID: 35533023
[TBL] [Abstract][Full Text] [Related]
38. Improved overall survival of melanoma of the head and neck treated with Mohs micrographic surgery versus wide local excision.
Hanson J; Demer A; Liszewski W; Foman N; Maher I
J Am Acad Dermatol; 2020 Jan; 82(1):149-155. PubMed ID: 31473297
[TBL] [Abstract][Full Text] [Related]
39. Mohs micrographic surgery concordance between Mohs surgeons and dermatopathologists.
Semkova K; Mallipeddi R; Robson A; Palamaras I
Dermatol Surg; 2013 Nov; 39(11):1648-52. PubMed ID: 24581313
[TBL] [Abstract][Full Text] [Related]
40. Factors Influencing General Dermatologists When Referring Patients With Head and Neck Melanoma for Mohs Micrographic Surgery: A Nationwide Cross-Sectional Survey.
Neill BC; Siscos SM; Bar AA; Seger EW; Latour E; Tolkachjov SN
Dermatol Surg; 2023 May; 49(5):451-455. PubMed ID: 36989088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
